Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Fast label-free multilayered histology-like imaging of human breast cancer by photoacoustic microscopy.

Wong TTW, Zhang R, Hai P, Zhang C, Pleitez MA, Aft RL, Novack DV, Wang LV.

Sci Adv. 2017 May 17;3(5):e1602168. doi: 10.1126/sciadv.1602168. eCollection 2017 May.

2.

Cost Analysis of a Surgical Consensus Guideline in Breast-Conserving Surgery.

Yu J, Elmore LC, Cyr AE, Aft RL, Gillanders WE, Margenthaler JA.

J Am Coll Surg. 2017 Aug;225(2):294-301. doi: 10.1016/j.jamcollsurg.2017.03.020. Epub 2017 Apr 14.

PMID:
28414115
3.

Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.

Pillai SG, Zhu P, Siddappa CM, Adams DL, Li S, Makarova OV, Amstutz P, Nunley R, Tang CM, Watson MA, Aft RL.

PLoS One. 2017 Jan 27;12(1):e0170761. doi: 10.1371/journal.pone.0170761. eCollection 2017.

4.

Uneventful versus Successful Reconstruction and Outcome Pathways in Implant-Based Breast Reconstruction with Acellular Dermal Matrices.

Qureshi AA, Broderick KP, Belz J, Funk S, Reaven N, Brandt KE, Tenenbaum MM, Margenthaler JA, Aft RL, Myckatyn TM.

Plast Reconstr Surg. 2016 Aug;138(2):173e-83e. doi: 10.1097/PRS.0000000000002402.

PMID:
27465177
5.

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.

Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ, Appleton CM, Zoberi I, Thomas MA, Gao F, Gillanders WE.

J Am Coll Surg. 2016 Aug;223(2):399-407. doi: 10.1016/j.jamcollsurg.2016.04.048. Epub 2016 May 20.

6.

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials.

Kroep JR, Charehbili A, Coleman RE, Aft RL, Hasegawa Y, Winter MC, Weilbaecher K, Akazawa K, Hinsley S, Putter H, Liefers GJ, Nortier JWR, Kohno N.

Eur J Cancer. 2016 Feb;54:57-63. doi: 10.1016/j.ejca.2015.10.011. Epub 2015 Dec 23.

7.

Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer.

Khwaja SS, Ivanovich J, DeWees TA, Ochoa L, Mullen DF, Thomas M, Margenthaler JA, Cyr A, Naughton M, Sanati S, Eberlein TJ, Gillanders WE, Aft RL, Zoberi JE, Zoberi I.

Cancer Med. 2016 Feb;5(2):230-8. doi: 10.1002/cam4.586. Epub 2015 Dec 21.

8.

CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.

Xiang J, Hurchla MA, Fontana F, Su X, Amend SR, Esser AK, Douglas GJ, Mudalagiriyappa C, Luker KE, Pluard T, Ademuyiwa FO, Romagnoli B, Tuffin G, Chevalier E, Luker GD, Bauer M, Zimmermann J, Aft RL, Dembowsky K, Weilbaecher KN.

Mol Cancer Ther. 2015 Nov;14(11):2473-85. doi: 10.1158/1535-7163.MCT-15-0252. Epub 2015 Aug 12.

9.

US breast cancer mortality trends in young women according to race.

Ademuyiwa FO, Gao F, Hao L, Morgensztern D, Aft RL, Ma CX, Ellis MJ.

Cancer. 2015 May 1;121(9):1469-76. doi: 10.1002/cncr.29178. Epub 2014 Dec 5.

10.

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM, Linette GP.

J Clin Invest. 2013 Aug;123(8):3383-94. doi: 10.1172/JCI68395. Epub 2013 Jul 11.

11.

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

Dehdashti F, Laforest R, Gao F, Shoghi KI, Aft RL, Nussenbaum B, Kreisel FH, Bartlett NL, Cashen A, Wagner-Johnston N, Mach RH.

J Nucl Med. 2013 Mar;54(3):350-7. doi: 10.2967/jnumed.112.111948. Epub 2013 Jan 28. Erratum in: J Nucl Med. 2013 May;54(5):827. Wagner-Johnson, Nina [corrected to Wagner-Johnston, Nina].

12.

Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.

Cyr A, Gao F, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Ann Surg Oncol. 2012 Oct;19(10):3185-91. doi: 10.1245/s10434-012-2547-4. Epub 2012 Aug 14.

13.

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer.

Aft RL, Naughton M, Trinkaus K, Weilbaecher K.

Br J Cancer. 2012 Jun 26;107(1):7-11. doi: 10.1038/bjc.2012.210. Epub 2012 May 22.

14.

Compromised margins following mastectomy for stage I-III invasive breast cancer.

Yu J, Al Mushawah F, Taylor ME, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

J Surg Res. 2012 Sep;177(1):102-8. doi: 10.1016/j.jss.2012.03.046. Epub 2012 Apr 10.

15.

Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors.

Atkins J, Al Mushawah F, Appleton CM, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

J Surg Res. 2012 Sep;177(1):109-15. doi: 10.1016/j.jss.2012.03.045. Epub 2012 Apr 10.

16.

Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.

Jeffe DB, Pérez M, Liu Y, Collins KK, Aft RL, Schootman M.

Breast Cancer Res Treat. 2012 Jul;134(1):379-91. doi: 10.1007/s10549-012-2048-y. Epub 2012 Apr 8.

17.

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.

Ma CX, Cai S, Li S, Ryan CE, Guo Z, Schaiff WT, Lin L, Hoog J, Goiffon RJ, Prat A, Aft RL, Ellis MJ, Piwnica-Worms H.

J Clin Invest. 2012 Apr;122(4):1541-52. doi: 10.1172/JCI58765. Epub 2012 Mar 26. Erratum in: J Clin Invest. 2012 Jul 2;122(7):2702.

18.

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Dehdashti F, Laforest R, Gao F, Aft RL, Dence CS, Zhou D, Shoghi KI, Siegel BA, Katzenellenbogen JA, Welch MJ.

J Nucl Med. 2012 Mar;53(3):363-70. doi: 10.2967/jnumed.111.098319. Epub 2012 Feb 13.

19.

Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.

Tran DD, Corsa CA, Biswas H, Aft RL, Longmore GD.

Mol Cancer Res. 2011 Dec;9(12):1644-57. doi: 10.1158/1541-7786.MCR-11-0371. Epub 2011 Oct 17.

20.

Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response.

Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

Ann Surg Oncol. 2012 Jan;19(1):253-8. doi: 10.1245/s10434-011-1877-y. Epub 2011 Jul 2.

21.

Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB.

Breast Cancer Res Treat. 2011 Nov;130(1):165-73. doi: 10.1007/s10549-011-1551-x. Epub 2011 May 8.

22.

Breast cancer in elderly women (≥ 80 years): variation in standard of care?

Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

J Surg Oncol. 2011 Mar 1;103(3):201-6. doi: 10.1002/jso.21799. Epub 2010 Nov 23.

23.

Are we overtreating papillomas diagnosed on core needle biopsy?

Cyr AE, Novack D, Trinkaus K, Margenthaler JA, Gillanders WE, Eberlein TJ, Ritter J, Aft RL.

Ann Surg Oncol. 2011 Apr;18(4):946-51. doi: 10.1245/s10434-010-1403-7. Epub 2010 Nov 3.

24.

Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden.

Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:303-11. doi: 10.1245/s10434-010-1255-1. Epub 2010 Sep 19.

25.

Changes in sexual problems over time in women with and without early-stage breast cancer.

Pérez M, Liu Y, Schootman M, Aft RL, Schechtman KB, Gillanders WE, Jeffe DB.

Menopause. 2010 Sep-Oct;17(5):924-37. doi: 10.1097/gme.0b013e3181d5dd26.

26.

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, Jeffe DB.

Breast Cancer Res Treat. 2010 Dec;124(3):835-44. doi: 10.1007/s10549-010-0912-1. Epub 2010 May 6.

27.

Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL.

Am J Surg. 2010 Apr;199(4):477-84. doi: 10.1016/j.amjsurg.2009.03.012.

28.

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.

Liu Y, Pérez M, Aft RL, Massman K, Robinson E, Myles S, Schootman M, Gillanders WE, Jeffe DB.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):675-80. doi: 10.1158/1055-9965.EPI-09-1051. Epub 2010 Feb 16. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1661.

29.

Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells.

Zhang F, Aft RL.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S41-3. doi: 10.4103/0973-1482.55140.

30.

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.

Lin Y, Lin S, Watson M, Trinkaus KM, Kuo S, Naughton MJ, Weilbaecher K, Fleming TP, Aft RL.

Breast Cancer Res Treat. 2010 Oct;123(3):691-9. doi: 10.1007/s10549-009-0664-y. Epub 2009 Dec 6.

31.

Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls.

Bailey EH, Pérez M, Aft RL, Liu Y, Schootman M, Jeffe DB.

Breast Cancer Res Treat. 2010 Jun;121(3):709-18. doi: 10.1007/s10549-009-0645-1. Epub 2009 Nov 21.

32.

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer.

Tan MC, Al Mushawah F, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

Am J Surg. 2009 Oct;198(4):520-5. doi: 10.1016/j.amjsurg.2009.06.004.

33.

The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy?

Pettit K, Swatske ME, Gao F, Salavaggione L, Gillanders WE, Aft RL, Monsees BS, Eberlein TJ, Margenthaler JA.

J Surg Oncol. 2009 Dec 1;100(7):553-8. doi: 10.1002/jso.21406.

34.

Predictors of primary breast abscesses and recurrence.

Bharat A, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

World J Surg. 2009 Dec;33(12):2582-6. doi: 10.1007/s00268-009-0170-8.

35.

Shared management of a rare necrotizing soft tissue infection of the breast.

Keune JD, Melby S, Kirby JP, Aft RL.

Breast J. 2009 May-Jun;15(3):321-3. doi: 10.1111/j.1524-4741.2009.00731.x. Review. No abstract available.

PMID:
19645797
36.

Method of breast cancer presentation and depressed mood 1 year after diagnosis in women with locally advanced disease.

Roth EB, Jeffe DB, Margenthaler JA, Aft RL.

Ann Surg Oncol. 2009 Jun;16(6):1637-41. doi: 10.1245/s10434-009-0445-1. Epub 2009 Apr 10.

37.

Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer.

Bharat A, Aft RL, Gao F, Margenthaler JA.

J Surg Oncol. 2009 Sep 1;100(3):248-51. doi: 10.1002/jso.21268.

PMID:
19330813
38.

Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy.

Mitchem J, Herrmann D, Margenthaler JA, Aft RL.

Am J Surg. 2008 Oct;196(4):519-22. doi: 10.1016/j.amjsurg.2008.06.016.

PMID:
18809054
39.

Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence.

Holwitt DM, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):562-5. doi: 10.1016/j.amjsurg.2008.06.009. Epub 2008 Aug 29.

40.

Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients.

Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):477-82. doi: 10.1016/j.amjsurg.2008.06.006. Epub 2008 Aug 23.

41.

Treatment and outcomes of patients with primary breast sarcoma.

Fields RC, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):559-61. doi: 10.1016/j.amjsurg.2008.06.010. Epub 2008 Aug 23.

PMID:
18723152
42.

Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women.

Zhang Q, Aft RL, Gross ML.

Chem Res Toxicol. 2008 Aug;21(8):1509-13. doi: 10.1021/tx8001737. Epub 2008 Aug 2.

43.

Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.

Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ, Weilbaecher KN, Fleming TP, Aft RL.

Clin Cancer Res. 2007 Sep 1;13(17):5001-9.

44.

Metastatic disease to the breast: the Washington University experience.

Vaughan A, Dietz JR, Moley JF, Debenedetti MK, Aft RL, Gillanders WE, Eberlein TJ, Ritter J, Margenthaler JA.

World J Surg Oncol. 2007 Jul 5;5:74.

45.

Perioperative outcomes and complications of laparoscopic ventral hernia repair.

Perrone JM, Soper NJ, Eagon JC, Klingensmith ME, Aft RL, Frisella MM, Brunt LM.

Surgery. 2005 Oct;138(4):708-15; discussion 715-6.

PMID:
16269300
46.

Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

Aft RL, Lewis JS, Zhang F, Kim J, Welch MJ.

Cancer Res. 2003 Sep 1;63(17):5496-504.

47.

Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram.

Schootman M, Jeffe DB, Reschke AH, Aft RL.

Cancer Causes Control. 2003 Jun;14(5):419-25.

PMID:
12946036
48.

2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.

Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL, Gius D.

Cancer Res. 2003 Jun 15;63(12):3413-7.

49.

Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.

Aft RL, Zhang FW, Gius D.

Br J Cancer. 2002 Sep 23;87(7):805-12.

50.

Degradation and covalent cross-linking of glutathione reductase by hemin.

Aft RL, Mueller GC.

Life Sci. 1985 Jun 3;36(22):2153-61.

PMID:
3999920

Supplemental Content

Support Center